Amdocs Limited (NASDAQ:DOX) Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. reduced its stake in Amdocs Limited (NASDAQ:DOX) by 20.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 529,324 shares of the technology company’s stock after selling 132,357 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.45% of Amdocs worth $46,305,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DOX. State Board of Administration of Florida Retirement System lifted its holdings in Amdocs by 7.9% in the first quarter. State Board of Administration of Florida Retirement System now owns 166,927 shares of the technology company’s stock worth $16,030,000 after acquiring an additional 12,178 shares during the last quarter. Boston Trust Walden Corp boosted its stake in Amdocs by 17.0% in the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company’s stock worth $48,803,000 after purchasing an additional 89,726 shares during the period. SG Americas Securities LLC boosted its stake in shares of Amdocs by 402.4% during the 2nd quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company’s stock valued at $12,230,000 after buying an additional 124,122 shares during the period. Sargent Investment Group LLC acquired a new stake in shares of Amdocs during the 2nd quarter valued at $289,000. Finally, Acadian Asset Management LLC boosted its stake in shares of Amdocs by 22.7% during the 1st quarter. Acadian Asset Management LLC now owns 1,395,894 shares of the technology company’s stock valued at $126,119,000 after buying an additional 258,343 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Stock Up 0.5 %

Shares of Amdocs stock opened at $88.48 on Tuesday. The business’s 50 day simple moving average is $87.48 and its 200 day simple moving average is $83.68. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04. The firm has a market cap of $10.40 billion, a PE ratio of 20.39, a P/E/G ratio of 1.42 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.24.

Amdocs (NASDAQ:DOX) last issued its earnings results on Wednesday, August 7th. The technology company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.60 by $0.02. Amdocs had a return on equity of 17.89% and a net margin of 10.21%. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.25 billion. During the same period in the previous year, the company posted $1.41 EPS. The firm’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, analysts predict that Amdocs Limited will post 5.67 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Monday, September 30th were given a dividend of $0.479 per share. The ex-dividend date was Monday, September 30th. This represents a $1.92 annualized dividend and a yield of 2.17%. Amdocs’s dividend payout ratio is currently 44.01%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DOX. StockNews.com upgraded shares of Amdocs from a “buy” rating to a “strong-buy” rating in a report on Friday, October 25th. Stifel Nicolaus assumed coverage on shares of Amdocs in a report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $102.00.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.